• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英夫利昔单抗治疗葡萄膜炎急性发作的疗效。

Efficacy of infliximab on the acute attack of uveitis.

作者信息

Alokaily Fahdah, Alsaleh Sulaiman, Al-Balawi Maryseon, Al-Rashidi Seham

机构信息

Department of Medicine, Division of Rheumatology, Riyadh Military Hospital, PO Box 7897, Riyadh 11159, Kingdom of Saudi Arabia.

出版信息

Saudi Med J. 2010 Jan;31(1):82-5.

PMID:20062906
Abstract

Uveitis is one of the major features of behcet's disease with relapse and remission pattern. Severe presentation can be resistant to the conventional treatment. Steroid has been used in the treatment of acute behcet's uveitis, although it especially has its own ocular complications when used in large doses. We describe to patients presented with acute uveitis while on treatment, uveitis was controlled by adding anti-tumor necrosis factor (TNF) and Infliximab.

摘要

葡萄膜炎是白塞病的主要特征之一,呈复发和缓解模式。严重的表现可能对传统治疗有抵抗性。类固醇已被用于治疗急性白塞病葡萄膜炎,尽管大剂量使用时尤其会有其自身的眼部并发症。我们描述了在治疗期间出现急性葡萄膜炎的患者,通过添加抗肿瘤坏死因子(TNF)和英夫利昔单抗,葡萄膜炎得到了控制。

相似文献

1
Efficacy of infliximab on the acute attack of uveitis.英夫利昔单抗治疗葡萄膜炎急性发作的疗效。
Saudi Med J. 2010 Jan;31(1):82-5.
2
Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.英夫利昔单抗治疗白塞病中对硫唑嘌呤、环孢素和皮质类固醇联合治疗耐药的葡萄膜炎的疗效:一项开放标签试验。
Arthritis Rheum. 2005 Aug;52(8):2478-84. doi: 10.1002/art.21231.
3
Adalimumab for sight-threatening uveitis in Behçet's disease.阿达木单抗用于治疗白塞病中威胁视力的葡萄膜炎。
Eye (Lond). 2007 Jun;21(6):824-5. doi: 10.1038/sj.eye.6702352. Epub 2006 Apr 7.
4
Induction of regulatory T cells by infliximab in Behcet's disease.英夫利昔单抗诱导白塞病调节性 T 细胞。
Invest Ophthalmol Vis Sci. 2011 Jan 21;52(1):476-84. doi: 10.1167/iovs.10-5916.
5
Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis.英夫利昔单抗多次给药治疗难治性葡萄膜视网膜炎型白塞病的疗效、安全性及药代动力学
J Rheumatol. 2004 Jul;31(7):1362-8.
6
Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects.七例白塞氏葡萄膜炎患者的抗TNF-α治疗:优势与争议点
Ann N Y Acad Sci. 2007 Sep;1110:474-84. doi: 10.1196/annals.1423.050.
7
Efficacy of switching to adalimumab in a patient with refractory uveitis of Behçet's disease to infliximab.一名白塞病难治性葡萄膜炎患者从英夫利昔单抗转换为阿达木单抗的疗效。
Clin Exp Rheumatol. 2011 Jul-Aug;29(4 Suppl 67):S93. Epub 2011 Sep 27.
8
Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease.英夫利昔单抗与传统疗法治疗白塞病视网膜血管炎的疗效比较。
Am J Ophthalmol. 2008 Dec;146(6):845-50.e1. doi: 10.1016/j.ajo.2008.09.010. Epub 2008 Oct 17.
9
Evaluation of the long-term efficacy and safety of infliximab treatment for uveitis in Behçet's disease: a multicenter study.评价英夫利昔单抗治疗 Behçet 病葡萄膜炎的长期疗效和安全性:一项多中心研究。
Ophthalmology. 2014 Oct;121(10):1877-84. doi: 10.1016/j.ophtha.2014.04.042. Epub 2014 Jun 18.
10
Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study.英夫利昔单抗治疗白塞病难治性后葡萄膜炎的长期疗效:一项24个月的随访研究。
Rheumatology (Oxford). 2007 Jul;46(7):1161-4. doi: 10.1093/rheumatology/kem101. Epub 2007 May 3.

引用本文的文献

1
Psoriasis in Northern Saudi Arabia: Clinical features and implications for quality of life.沙特阿拉伯北部的银屑病:临床特征及对生活质量的影响。
J Public Health Res. 2022 Oct 20;11(4):22799036221123961. doi: 10.1177/22799036221123961. eCollection 2022 Oct.
2
Update on the therapy of Behçet disease.白塞病治疗的最新进展。
Ther Adv Chronic Dis. 2014 May;5(3):112-34. doi: 10.1177/2040622314523062.
3
Etanercept therapy in Behçet's disease. The tight control strategy in refractory disease.依那西普治疗白塞病。难治性疾病的严格控制策略。
Z Rheumatol. 2014 Sep;73(7):650-6. doi: 10.1007/s00393-013-1307-6.
4
[Off-label use of infliximab].[英夫利昔单抗的超说明书用药]
Hautarzt. 2013 Oct;64(10):757-61. doi: 10.1007/s00105-013-2596-z.
5
Efficacy of infliximab in refractory Behçet's disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients.英夫利昔单抗治疗难治性白塞病相关性及特发性后段葡萄膜炎的疗效:一项对50例患者的前瞻性随访研究。
Biologics. 2012;6:5-12. doi: 10.2147/BTT.S27343. Epub 2011 Dec 29.